| Expression and regulation of the myc proto-oncogene in the pituitary gland of rainbow trout. | pituitary, |
| Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma. | skin, |
| Restriction fragment length polymorphism of the L-myc oncogene in non-Hodgkin s lymphoma patients from India. | lymphoma, |
| Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines. | lung, |
| Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas. | endometrial, |
| [S allele of the L-myc oncogene is associated with lung cancer metastases in patients from Moldova]. | lung, |
| The prognostic significance of c-myc oncogene expression in uveal melanoma. | skin, |
| Molecular genetic alterations of c-myc oncogene in superficial and locally advanced bladder cancer. | bladder, |
| The clinical significance of c-myc oncogene expression in melanomas of the scalp. | skin, |
| Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells. | leukemia, |
| Overexpression of the c-myc proto-oncogene in colorectal carcinoma is associated with a reduced mortality that is abrogated by point mutation of the p53 tumor suppressor gene. | colorectal, |
| Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. | lymphoma, |
| S allele of L-MYC oncogene is associated with metastatic lung cancer in patients from Moldova. | lung, |
| Infrequent presence of anti-c-Myc antibodies and absence of c-Myc oncoprotein in sera from lung cancer patients. | lung, |
| Methylation status of the 3rd exon of the c-MYC oncogene in B-cell malignancies. | None |
| [Effects of lithium chloride and harringtonine on the differentiation, proliferation and c-myc proto-oncogene expression of HL-60 cells]. | None |
| Oncogene Expression and Cellular Radiation Resistance: A Modulatory Role for c-myc. | None |
| The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. | None |
| Development of a polyclonal antibody with defined specificity against synthetic peptides from the N-myc oncoprotein using multiple antigen peptide and hemocyanin conjugation methods. | None |
| Expression of the c-myc proto-oncogene is essential for HIV-1 infection in activated T cells. | None |